Skip to main content
. Author manuscript; available in PMC: 2010 Jan 29.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 5;63(1):65. doi: 10.1007/s00280-008-0712-z

Fig. 1.

Fig. 1

a Percentage change in APTT (%) with respect to time post PI-88 administration (in h). b Plasma concentration of PI-88 (ug/ml) versus time post dose (h)